SAN RAFAEL, Calif., April 18, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. BMRN today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Wednesday, April 25, at 4:30 p.m. ET to discuss first quarter 2018 financial results and provide a general business update.

Dial-in Number 

U.S. / Canada Dial-in Number: (866) 502-9859

International Dial-in Number: (574) 990-1362

Conference ID: 1665515

Replay Dial-in Number: (855) 859-2056

Replay International Dial-in Number: (404) 537-3406

Conference ID: 1665515

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.biomarin.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com.

View original content with multimedia:http://www.prnewswire.com/news-releases/biomarin-to-host-first-quarter-2018-financial-results-conference-call-and-webcast-on-wednesday-april-25-at-430pm-et-300631293.html

SOURCE BioMarin Pharmaceutical Inc.